Announcements Trials
Browse Landscape

Phase

Phase 3 17Phase 2 9Phase NA 2Phase 2/3 1

Status

Completed 7Terminated 4Recruiting 4Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Standard of Care 41Methods 37Practice Guidelines as Topic 36Exercise 36Educational Status 36Surveys and Questionnaires 33Early Intervention, Educational 32Radiotherapy 25Radiosurgery 24Magnetic Resonance Spectroscopy 23Interviews as Topic 20Blood Specimen Collection 17Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 12Counseling 12Radiation 11Palliative Care 11Nutrition Assessment 11Specimen Handling 9Resistance Training 9Proton Therapy 8Mammography 8Biopsy 8Yoga 7Radiofrequency Ablation 7Drug Therapy 7Diet Therapy 7Control Groups 7Referral and Consultation 6Radiation Dose Hypofractionation 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Observation × Clear all
NCT02194738 2026-05-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02492607 2026-01-26

LORD

The Netherlands Cancer Institute

Phase NA Active not recruiting
2,500 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡